Acyclovir Eye Drops | Artemisine Medicines Technology

Name: Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL
Brand: Artemisine Medicines Technology Co., Ltd.

Ophthalmic

Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL

● Acyclovir is a purine nucleoside analogue with high in vitro activity against herpes simplex virus types 1 and 2 and varicella-zoster virus [1]
● Mechanism: in herpes-infected cells, acyclovir is phosphorylated by viral thymidine kinase and the triphosphate inhibits viral DNA polymerase and is incorporated into viral DNA, disrupting viral DNA synthesis [1]
● Selectively taken up and activated by herpes-infected cells, resulting in low toxicity to uninfected human cells [1]
● Rapidly absorbed by the corneal epithelium and superficial ocular tissues, penetrating the aqueous humour to therapeutic levels (about 7.5 mmol/l after topical ophthalmic use) [1]
● Sterile ophthalmic solution, acyclovir 1% (10 mg/mL), in 0.4 mL single-dose units [1][2]

Product Name	Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL
Dosage Form	Ophthalmic
Strength	1% (10 mg/mL) 0.4 mL
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Ophthalmic

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

● Treatment of herpes simplex keratitis [1] ● Antiviral medication is the mainstay of treatment for herpetic epithelial disease of the eye [2] ● Acyclovir 3% ophthalmic ointment is included on the WHO List of Essential Medicines as a first-line ophthalmological anti-infective agent [3]

💧Administration▾

● For ocular use only; not for injection or oral intake [1] ● Topical ophthalmic acyclovir is used regularly five times a day (at approximately 4-hour intervals) [1][2] ● Patients should be informed that transient mild stinging immediately following application may occur [1] ● Patients should avoid wearing contact lenses when using the product [1] ● In case of a bacterial co-infection, additional antibiotic therapy must be carried out [1]

⚖️Dosage▾

The treatment schedule below refers to reference ophthalmic acyclovir products (3% eye ointment) used for herpes simplex keratitis; for the eye-drops presentation, instil the volume prescribed in the approved label of the product concerned [1][2]. ● Continue treatment for at least 3 days after healing is complete [1] ● Follow the approved label of the product concerned for the exact number of drops per instillation [1][2]

⚠️Precautions & Warnings▾

● Contraindicated in patients with hypersensitivity to acyclovir or to any excipient, and in patients hypersensitive to valaciclovir [1] ● Very common: superficial punctate keratopathy — did not necessitate early termination of therapy and healed without sequelae [1] ● Uncommon: transient mild stinging or burning immediately after application, conjunctivitis; rare: blepharitis [1] ● Very rare: immediate hypersensitivity reactions, including angioedema and urticaria [1] ● Insufficient clinical data for deep corneal defects and for combined use with topical corticosteroids [1] ● Pregnancy: use can be considered when necessary — systemic exposure after ophthalmic use is expected to be negligible; breastfeeding: the dose received by the nursing infant would be insignificant [1] ● May affect visual ability — caution is advised when driving or using machines [1] ● Storage: store below 25 °C; once opened, the product may be stored for a maximum of 28 days at 25 °C [1] ● Keep out of the reach of children [1] For full prescribing information, refer to the approved product label / Summary of Product Characteristics of the product concerned [1][2][3].

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL — Frequently Asked Questions

Which documents are provided for Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL registration?

Every batch of Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL?

MOQ and lead time for Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.

Which markets have you exported ophthalmic products to?

We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL controlled?

Acyclovir Eye Drops 1% (10 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›